Septerna Inc (SEPN) Short-Term Debt to Capital
Septerna Inc (SEPN) automates substance synthesis using algorithms, although final human trials remain the responsibility of experts. The market price confirmed by this chart, where the indicator stands at 0.01, links these technologies to the high margins of GPCR drugs and the demand for tablet forms. The company's operations take place within a safe geopolitical environment, as immunological developments are shielded from trade wars and sanction restrictions.
Metric breakdowns and analytics for septerna.com (SEPN)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:Septerna Corp, SEPN
Septerna Inc (SEPN) specializes in developing GPCR-targeted drugs, relying on investments and partnerships with pharmaceutical behemoths. The ratio of current liabilities to equity quantifies the issuer's financial discipline, allowing for an assessment of excessive credit load risk and the probability of asset dilution, which is clearly tracked via the short leverage indicator to ensure compliance with investment declarations.
Competing companies
Argenx (ARGX) - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital BioNTech Pharma (BNTX)|Short-Term Debt to Capital ABVX (Abivax Pharma)|admabiologics.com - Short-Term Debt to Capital|Short-Term Debt to Equity Protagonist (PTGX)|IMVT: Ratio of Short-Term Indebtedness to Capital|KNSA (Kiniksa Pharmaceuticals Ltd) - Short-Term Debt to Equity|Grifols Biemat (GRFS) - Short-Term Debt to Equity Ratio|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com (CLDX)|Aurinia Pharmaceuticals Inc. (AUPH) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital BioCryst Pharmaceuticals, Inc. (BCRX)|Short-Term Debt to Capital VERA|Dianthus Corp - Short-Term Debt to Capital Coefficient|PHVS: Short-Term Debt to Equity|ABCL: Short-Term Debt to Equity Ratio|TRML (Tourmaline Bio) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|PHAR (Pharming) - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital NKTR|Short-Term Debt to Equity Upstream Bio Inc UPB|Short-Term Debt to Capital Ratio zenasbio.com (ZBIO)|IMNM: Short-Term Debt to Capital|Gossamer Bio Inc - Current Liabilities to Capital|Short-Term Debt to Equity KALV (KalVista Pharmaceuticals Inc)|PVLA - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital SVRA|RIGL (rigel.com) - Current Liabilities to Capital|Short-Term Debt to Equity AnaptysBio ANAB|Current Liabilities to Equity Astria Therapeutics Inc (ATXS)|Short-Term Debt to Equity Ratio enGene Bio|Short-Term Loans to Capital Ratio rapt.com (RAPT)|JBIO: Short-Term Debt to Capital|aclaristx.com - Current Liabilities to Capital|Short-Term Debt to Equity Kyverna Therapeutics, Inc. (KYTX)|TLSA: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Cabaletta Bio, Inc|Ventyx Biosciences, Inc (VTYX) - Short-Term Debt to Capital Ratio|THTX (Theratechnologies Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital avalotx.com (AVTX)|Eledon Pharmaceuticals, Inc. (ELDN) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Agenus, Inc. (AGEN)|Short-Term Debt to Capital CLYM|zurabio.com - Short-Term Debt to Capital Coefficient|aTyr Pharma, Inc. (ATYR) - Short-Term Debt to Equity|ADAG - Short-Term Debt to Capital Ratio|IMA (ikenaoncology.com) - Short-Term Debt to Capital|STTK (Shattuck Labs) - Short-Term Debt to Equity Ratio|EQ: Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient Connect Pharma|Immunic, Inc. - Short-Term Debt to Capital|Current Liabilities to Capital ATRA (atarabio.com)|InflaRx (IFRX) - Short-Term Debt to Equity|X4 Pharmaceuticals Inc. - Current Liabilities to Equity|Adicet (ACET) - Short-Term Debt to Equity|CELU: Short-Term Debt to Capital Ratio|Short-Term Debt to Equity INmune Bio, Inc. (INMB)|barinthusbio.com (BRNS) - Current Liabilities to Equity|KZR - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital SAB Biotherapeutics Inc.|Short-Term Debt to Capital AKTX|Short-Term Debt to Capital ENLV (enlivex.com)|Short-Term Debt to Equity Q32 Bio|geovax.com - Ratio of Short-Term Indebtedness to Capital|EDSA: Short-Term Debt to Equity|IBIO - Short-Term Debt to Equity Ratio|CARM: Short-Term Debt to Capital|Short-Term Debt to Capital XTL Bio|BOLT - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital HCW Biologics Inc|APVO (Aptevo Therapeutics) - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient AIM (aimimmuno.com)|Aditxt, Inc. - Short-Term Debt to Equity|GRI Bio Corporation - Short-Term Debt to Equity Ratio|XRTX: Short-Term Debt to Equity|reshapelifesciences.com (HIND) - Short-Term Debt to Equity Ratio|REVB: Short-Term Debt to Equity Ratio|INDP (Indaptus Therapeutics Inc) - Short-Term Debt to Capital|Short-Term Debt to Equity Scinai (SCNI)|Short-Term Debt to Capital Ratio CalciMedica Corp|Affimed - Short-Term Debt to Capital|Current Liabilities to Capital ALLK (allakos.com)|Short-Term Debt to Equity HOOK|Short-Term Debt to Capital Coefficient IGM Biosciences Inc. IGMS|ITOS (iTeos) - Short-Term Debt to Capital|OCEA: Current Liabilities to Capital|Short-Term Debt to Equity TC Biopharm (TCBP)|Current Liabilities to Equity thirdharmonicbio.com